EMEA: Guideline on the Development of Medicinal Products for the Treatment of Post-Traumatic Stress Disorder (PTSD)

The aim of this guideline is to provide guidance for the planning of clinical studies concerning the treatment of posttraumatic stress disorder (PTSD), the only psychiatric disorder with a causal agent (the traumatic event) being part of the diagnostic criteria. There are several SSRIs that are currently used in the treatment of PTSD.